Advertisement
Advertisement
PAHC
Phibro Animal Health Corporation Class A
35.31
USDSponsored
-1.01
-2.78%
Aug 24, 15:59 UTC -4
Closed
After-Market
35.30
-0.02
-0.04%
PAHC Earnings Reports
Positive Surprise Ratio
PAHC beat 26 of 41 last estimates.
63%
Next Report
In 2 Days
Date of Next Report
Aug 26, 2026
Estimate for Q4 26 (Revenue/ EPS)
$388.87M
/$0.72
Implied change from Q3 26 (Revenue/ EPS)
+1.40%
/-5.26%
Implied change from Q4 25 (Revenue/ EPS)
+2.69%
/+28.57%
Phibro Animal Health Corporation Class A earnings per share and revenue
On May 06, 2026, PAHC reported earnings of 0.76 USD per share (EPS) for Q3 26, beating the estimate of 0.72 USD, resulting in a 4.50% surprise. Revenue reached 383.50 million, compared to an expected 374.36 million, with a 2.44% difference. The market reacted with a -26.22% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 0.72 USD, with revenue projected to reach 388.87 million USD, implying an decrease of -5.26% EPS, and increase of 1.40% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Omeros Corporation
Report Date
Aug 12, 2026 For Q2 26
Estimate
-$0.27
Actual
$0.02
Surprise
+107.31%
Lumexa Imaging Holdings, Inc. Common Stock
Report Date
Aug 12, 2026 For Q2 26
Estimate
$0.16
Actual
$0.20
Surprise
+24.07%
CeriBell, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.48
Actual
-$0.51
Surprise
-6.10%
Valneva SE - ADR
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.34
Surprise
-243.33%
Brainsway Ltd. - ADR
Report Date
Aug 12, 2026 For Q2 26
Estimate
$0.15
Actual
$0.14
Surprise
-7.65%
Capricor Therapeutics Inc
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.60
Actual
-$0.70
Surprise
-16.32%
Village Farms International, Inc. Common Shares
Report Date
Aug 10, 2026 For Q2 26
Estimate
$0.02
Actual
$0.06
Surprise
+154.24%
Organigram Global Inc. Common Shares
Report Date
Aug 11, 2026 For Q3 26
Estimate
$0.00
Actual
-$0.06
Surprise
-2,480.74%
FitLife Brands, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
$0.19
Actual
$0.20
Surprise
+0.55%
Immucell Corp
Report Date
Aug 13, 2026 For Q2 26
Estimate
-Actual
$0.20
Surprise
-
FAQ
What were Phibro Animal Health Corporation Class A's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Phibro Animal Health Corporation Class A reported EPS of $0.76, beating estimates by 4.5%, and revenue of $383.50M, 2.44% above expectations.
How did the market react to Phibro Animal Health Corporation Class A's Q3 2026 earnings?
The stock price moved down -26.22%, changed from $58.50 before the earnings release to $43.16 the day after.
When is Phibro Animal Health Corporation Class A expected to report next?
The next earning report is scheduled for Aug 26, 2026.
What are the forecasts for Phibro Animal Health Corporation Class A's next earnings report?
Based on --
analysts, Phibro Animal Health Corporation Class A is expected to report EPS of $0.72 and revenue of $388.87M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement